ARCHIVES

Emphasis On Early Disease In Clinical Trials, Early Lung Cancer Detection Seen As “Landmark”

This article is from The Cancer Letter archive.

Vol. 01 No. 38 | September 19, 1975

Download PDF Visit The Full Archive

Related Articles

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

January 2, 1981

Survey Finds 70 Percent of Oncologists Prescribe Avastin Off-Label For Ovarian Cancer

August 30, 2013

Funding opportunities listed.

September 24, 2004

In Brief: Sharp Won’t Take MIT Presidency; Brow returns To NCI; Goldman Succeeds Lawrence At MCV

March 9, 1990

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006